ONLINE
ORDER


| Reference Standard as Aliquots | |||||||
| Product Batch | Therapeutic Expiry Date* | Brand & Origin | Amount per Aliquot | Quality Standard | Product Concentration | Volume per Aliquot | Storage Temperature |
| Denosumab 1080147A | 2019.07 | Prolia® DE | 3 mg | clinical-grade | 60 mg/mL | 50 µL | -70°C |
| Denosumab 1082130A | 2019.10 | Prolia® DE | 3 mg | clinical-grade | 60 mg/mL | 50 µL | -70°C |
| Denosumab 1087971A | 2020.04 | Prolia® DE | 3 mg | clinical-grade | 60 mg/mL | 50 µL | -70°C |
| Denosumab 1090173B | 2020.09 | Prolia® DE | 3 mg | clinical-grade | 60 mg/mL | 50 µL | -70°C |
| Denosumab 1094444A | 2021.01 | Prolia® DE | 3 mg | clinical-grade | 60 mg/mL | 50 µL | -70°C |
| Denosumab 1114463 | 2022.06 | Prolia® DE | 3 mg | clinical-grade | 60 mg/mL | 50 µL | -70°C |
| Biosimilars as Aliquots | |||||||
| Product Batch | Therapeutic Expiry Date* | Brand & Origin | Amount per Aliquot | Quality Standard | Product Concentration | Volume per Aliquot | Storage Temperature |
| Denosumab | Xgeva® | 3 mg | clinical-grade | 70,6 mg/mL | 42,5 µL | -70°C | |

이전